Maheshwari Keerti, Gupta Rashi, Sharma Ruchika, Kaur Amanpreet, Vashist Atul, Aggarwal Geeta
Centre for Precision Medicine and Pharmacy, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
Department of Medical Laboratory Technology, School of Allied Health Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
Crit Rev Microbiol. 2024 Aug 19:1-16. doi: 10.1080/1040841X.2024.2391488.
In recent times, the nasal region has emerged as a distinctive and dynamic environment where a myriad of microbial communities establish residence from infancy, persisting as both commensal and opportunistic pathogens throughout the lifespan. Understanding the coexistence of microorganisms in respiratory mucosal layers, their potential for infections, and the underlying molecular mechanisms shaping these interactions is crucial for developing efficient diagnostic and therapeutic interventions against respiratory and neurodegenerative diseases. Despite significant strides in understanding the olfactory system's nexus with nasal microbiota, comprehensive correlations with neurological diseases still need to be discovered. The nasal microbiome, a sentinel in immune defense, orchestrates a delicate equilibrium that, when disrupted, can precipitate severe respiratory infections, including Chronic Rhinosinusitis, Chronic obstructive pulmonary disorder (COPD), and Asthma, and instigate a cascade effect on central nervous system diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Multiple sclerosis (MS). This review aims to redress this imbalance by meticulously exploring the anatomical and microbiological nuances of the nasal mucosal surface in health and disease. By delineating the molecular intricacies of these interactions, this review unravels the molecular mechanisms that govern the intricate nexus between nasal microbiota dysbiosis, olfactory dysfunction, and the progression of respiratory and neurological diseases.
近年来,鼻腔区域已成为一个独特且充满活力的环境,从婴儿期开始就有无数微生物群落在此定居,并在整个生命周期中作为共生菌和机会致病菌持续存在。了解呼吸道黏膜层中微生物的共存情况、它们引发感染的可能性以及塑造这些相互作用的潜在分子机制,对于开发针对呼吸道疾病和神经退行性疾病的有效诊断和治疗干预措施至关重要。尽管在理解嗅觉系统与鼻腔微生物群的联系方面取得了重大进展,但与神经疾病的全面关联仍有待发现。鼻腔微生物群作为免疫防御的哨兵,协调着一种微妙的平衡,一旦这种平衡被打破,就可能引发严重的呼吸道感染,包括慢性鼻窦炎、慢性阻塞性肺疾病(COPD)和哮喘,并对中枢神经系统疾病如阿尔茨海默病(AD)、帕金森病(PD)和多发性硬化症(MS)产生连锁反应。本综述旨在通过精心探索健康和疾病状态下鼻腔黏膜表面的解剖学和微生物学细微差别来纠正这种不平衡。通过阐述这些相互作用的分子复杂性,本综述揭示了控制鼻腔微生物群失调、嗅觉功能障碍以及呼吸道和神经疾病进展之间复杂联系的分子机制。